UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
Notable Analyst Rating Changes 9/18: ETFC, SNDK, TOL, SBUX, PG, AMED Upgraded; SCHW, GENZ, MDC, IMAX, MOT Downgraded
-
UBS Upgrades Amedisys (AMED) to Buy, $57 Price Target
-
Morning Movers 9/3: UPI, SVA, CRIS, BNVI, ZUMZ, VICL, MEDQ Higher; AMED, INWK, HOV, FDO, VG Lower
-
Notable Analyst Rating Changes 8/26: STJ, GMR, KMT, CP Upgraded; BKC, AMED, MDAS Downgraded
-
UBS Downgrades Amedisys (AMED) to Neutral
-
Morning Movers 7/28: SPSS, ARIA, VM, KFN, LCRD Higher; USU, CPO, ABK, ODP, TRID Lower
-
Trading Radar for 4/28: Bristol-Myers Squibb (BMY), Pfizer (PFE), BP (BP), Sun Micro (JAVA), Deutsche Bank (DB), E*TRADE (ETFC), Level 3 (LVLT) Report; Consumer Confidence Due
-
Morning Movers 1/06: Indevus Pharmaceuticals (IDEV) Soars On Buyout, Garmin (GRMN) Lower on Downgrade
-
Notable Analyst Rating Changes 11/20: DSX, BIDU, ATR Upgraded; EGLE, SOL, AMED, PAY Downgraded
-
UBS Upgrades Amedisys (AMED) to Buy
-
Notable Analyst Rating Changes 8/22: CHS, CRM, BCSI, RRC Upgraded; LVS, BKC, PSUN Downgraded
-
Notable Analyst Rating Changes 8/19: MA, DKS, AFFY Upgraded; DRI, ADP, BIOF Downgraded
